Advances in Promoting the Efficacy of Chimeric Antigen Receptor T Cells in the Treatment of Hepatocellular Carcinoma

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is one of the most common and deadly cancers worldwide. Its insidious onset, rapid disease progression, and poor prognosis make it difficult to treat. Chimeric antigen receptor (CAR)-T cell therapy, a popular treatment in recent years, has demonstrated...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Jie, Yang, Dashuai, Ding, Youming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599749/
https://www.ncbi.nlm.nih.gov/pubmed/36291802
http://dx.doi.org/10.3390/cancers14205018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599749/
https://www.ncbi.nlm.nih.gov/pubmed/36291802
http://dx.doi.org/10.3390/cancers14205018

Ejemplares similares